Revolutionary New Drug Offers 99.9% Protection Against HIV
|
The US FDA has approved lenacapavir, a groundbreaking
long-acting HIV prevention drug that offers near-complete protection
with just two ... |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...